Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank14
3Y CAGR-15.5%
5Y CAGR-19.7%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-15.5%/yr
vs +8.0%/yr prior
5Y CAGR
-19.7%/yr
Recent acceleration
Acceleration
-23.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$88.53M+26.3%
2024$70.09M-53.7%
2023$151.53M+3.3%
2022$146.69M-37.7%
2021$235.37M-11.3%
2020$265.30M+81.1%
2019$146.52M+36.0%
2018$107.73M-